FDA Inspection 1043417 — Novo Nordisk Production Ireland Limited
The FDA completed an inspection of Novo Nordisk Production Ireland Limited on January 25, 2018 in Athlone. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 25, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Athlone (Ireland)